Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.330
-0.270 (-7.50%)
At close: Jun 9, 2026, 4:00 PM EDT
3.350
+0.020 (0.60%)
After-hours: Jun 9, 2026, 7:57 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $7.64 million as of June 9, 2026. Its market cap has increased by 182.79% in one year.
Market Cap
7.64M
Enterprise Value
486.73K
1-Year Change
182.79%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $7.64M, a decrease of -97.64%. That is a compound annual growth rate of -56.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 8.26M | 485.36% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.76M |
| Curanex Pharmaceuticals | 8.59M |
| Addex Therapeutics | 8.56M |
| Bio Green Med Solution | 8.28M |
| Aptorum Group | 8.23M |
| Imunon | 8.21M |
| AIM ImmunoTech | 8.12M |
| NuCana | 8.12M |